Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.
Saved in:
| Title: | Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. |
|---|---|
| Authors: | Bonnefoi, H.1, Litière, S.2, Piccart, M.3, MacGrogan, G.1, Fumoleau, P.4, Brain, E.5, Petit, T.6, Rouanet, P.7, Jassem, J.8, Moldovan, C.9, Bodmer, A.10,11, Zaman, K.12, Cufer, T.13,14, Campone, M.15,16, Luporsi, E.17, Malmström, P.18,19, Werutsky, G.2, Bogaerts, J.2, Bergh, J.20,21, Cameron, D. A.1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23 |
| Source: | Annals of Oncology. Jun2014, Vol. 25 Issue 6, p1128-1136. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdu118 |
